U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C11H19N5
Molecular Weight 221.3021
Optical Activity ( - )
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of JNJ-39758979

SMILES

CC(C)C1=CC(=NC(N)=N1)N2CC[C@@H](N)C2

InChI

InChIKey=COOGVHJHSCBOQT-MRVPVSSYSA-N
InChI=1S/C11H19N5/c1-7(2)9-5-10(15-11(13)14-9)16-4-3-8(12)6-16/h5,7-8H,3-4,6,12H2,1-2H3,(H2,13,14,15)/t8-/m1/s1

HIDE SMILES / InChI
JNJ-39758979 is a histamine H4 receptor antagonist which clinical development for asthma and atopic dermatitis was halted during phase II because of the observation of idiosyncratic drug-induced agranulocytosis in two subjects.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
12.5 nM [Ki]
PubMed

PubMed

TitleDatePubMed
Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H₄ receptor antagonists.
2014 Mar 27
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.
2015 Jul
Patents
Name Type Language
JNJ-39758979
Code English
JNJ 39758979 [WHO-DD]
Common Name English
2-PYRIMIDINAMINE, 4-((3R)-3-AMINO-1-PYRROLIDINYL)-6-(1-METHYLETHYL)-
Systematic Name English
JNJ-39758979, (-)-
Code English
JNJ39758979
Code English
Code System Code Type Description
FDA UNII
5RV7T5BNMG
Created by admin on Sat Dec 16 09:42:19 GMT 2023 , Edited by admin on Sat Dec 16 09:42:19 GMT 2023
PRIMARY
PUBCHEM
24994634
Created by admin on Sat Dec 16 09:42:19 GMT 2023 , Edited by admin on Sat Dec 16 09:42:19 GMT 2023
PRIMARY
CAS
1046447-90-8
Created by admin on Sat Dec 16 09:42:19 GMT 2023 , Edited by admin on Sat Dec 16 09:42:19 GMT 2023
PRIMARY